INmune Bio, Inc. (INMB) - Earnings growth in current year
The YoY net income per share dynamics for INmune Bio, Inc. (INMB) are based on the flawless management of its biotech platform and the transparency of Alzheimer's data. Uninterrupted reagent supply through diversified channels supports research, while a unique approach to immunotherapy lays the foundation for future pricing power. The value of 67.50 represents the current metric, capturing the issuer's real profit growth amid tight Fed policy.
Analytical breakdowns and data insights for company INmune Bio, Inc. (INMB)
- price and consensus price forecast:
- market capitalization indicators:
- book capitalization data:
- debt and liquidity details:
Total Debt to Capital Coefficient INmune Bio, Inc.|INMB - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio inmunebio.com|INMB - Company Debts|Debt to Book Value INmune Bio Corporation|INMB - Company Long-Term Liabilities|Company Short-Term Debts INmune Bio|Immediate Liquidity Ratio inmunebio.com
- earnings and market ratios statistics:
INMB - Net Profit|Expected Net Profit INmune Bio, Inc.|INMB - Price to Earnings Ratio|Future Price to Earnings Multiple INmune Bio Corporation|INMB - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INmune Bio Corporation|INMB - Operating profit EBITDA|Net earnings per share for the last four quarters INmune Bio|INMB - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months inmunebio.com|INMB - Net earnings per share growth this year|Expected earnings per share trend next year INmune Bio, Inc.
Basic company analysis:INMB, INmune Bio Inc
This indicator reflects earnings per share dynamics by measuring the annual growth rate of net income. The calculation is based on the percentage ratio of current EPS to the previous year's value. By analyzing the annual EPS change scale, an investor determines the business scaling speed. For INmune Bio, Inc. (INMB), which maintains a minimal ecological footprint through production outsourcing, this metric is critically important. It demonstrates the efficiency of cost management for clinical trials.
Key competitors
Net earnings per share growth this year argenx N.V.|Net earnings per share growth this year BNTX|Earnings growth in current year abivax.com|Earnings per share growth in current year ADMA Biologics (ADMA)|protagonist-inc.com - Earnings per share growth this year|Earnings growth in current year IMVT (Immunovant)|Kiniksa Pharmaceuticals, Ltd. (KNSA) - Earnings per share growth rate in current year|Grifols Group - Earnings growth in current year|Expected net earnings per share growth this year Adaptive Biotechnologies Inc. ADPT|Celldex Therapeutics (CLDX) - Earnings per share growth in current year|Earnings per share growth this year AUPH|Earnings per share growth in current year BioCryst Pharmaceuticals|Net earnings per share growth this year Vera Therapeutics Inc (VERA)|Net earnings per share growth this year DNTH (Dianthus Pharma)|Earnings growth in current year Pharvaris Pharma (PHVS)|Earnings per share growth in current year AbCellera Biologics ABCL|TRML: Earnings per share growth this year|Precigen - Earnings growth in current year|Earnings per share growth rate in current year Pharming Group NV|NKTR (Nektar) - Net earnings per share growth this year|Upstream Pharma - Earnings per share increase in current year|ZBIO (Zenas Biopharma Inc) - Earnings growth in current year|Earnings per share growth in current year IMNM|Earnings growth in current year GOSS|Expected net earnings per share growth this year KalVista Pharma|Earnings per share growth in current year Septerna Corp SEPN|Pieris Corp (PVLA) - Earnings per share growth rate in current year|SVRA: Net earnings per share growth this year|Earnings per share increase in current year RIGL (rigel.com)|ANAB: Earnings growth in current year|ATXS - Expected net earnings per share growth this year|Earnings per share growth in current year enGene Bio|Earnings per share growth this year RAPT (RAPT Therapeutics Inc.)|Earnings growth in current year JBIO|Net earnings per share growth this year aclaristx.com ACRS|Kyverna Therapeutics, Inc. - Net earnings per share growth this year|Expected net earnings per share growth this year Tiziana Life Sciences Ltd. (TLSA)|Cabaletta Bio, Inc - Earnings growth in current year|Expected net earnings per share growth this year Ventyx Biosciences, Inc VTYX|Theratechnologies Inc. (THTX) - Earnings per share growth in current year|Earnings per share growth this year AVTX|Earnings per share growth in current year Eledon Pharmaceuticals, Inc.|Net earnings per share growth this year Agenus, Inc. (AGEN)|Earnings growth in current year CLYM|Earnings per share growth in current year ZURA (Zura Bio Ltd)|Earnings per share growth in current year aTyr Pharma, Inc. ATYR|ADAG (Adagene Inc) - Earnings per share trend in current year|Ikena Oncology, Inc. - Earnings growth in current year|Earnings per share increase in current year STTK (Shattuck Labs, Inc.)|EQ: Earnings growth in current year|Connect Biopharma Holdings Limited (CNTB) - Earnings growth in current year|Earnings per share growth in current year Immunic Therapeutics|ATRA: Earnings per share increase in current year|Earnings per share growth in current year InflaRx N.V. (IFRX)|Net earnings per share growth this year X4 Pharmaceuticals Inc. XFOR|Earnings growth in current year ACET (Adicet Bio, Inc.)|Earnings growth in current year Celularity Inc CELU|BRNS: Net earnings per share growth this year|Earnings per share increase in current year KZR (kezarlifesciences.com)|SABS: Earnings growth in current year|AKTX - Expected net earnings per share growth this year|Earnings per share growth in current year Enlivex Therapeutics Ltd|Net earnings per share growth this year Q32 Bio Corp (QTTB)|Earnings per share growth in current year GeoVax Labs, Inc. (GOVX)|Net earnings per share growth this year edesabiotech.com EDSA|iBio - Net earnings per share growth this year|Earnings growth in current year Carisma Therapeutics Inc CARM|XTLB - Earnings per share growth in current year|BOLT (Bolt Biotherapeutics) - Earnings per share growth this year|HCWB: Earnings growth in current year|Earnings per share growth rate in current year Aptevo Therapeutics Inc. (APVO)|AIM (AIM ImmunoTech Inc.) - Earnings growth in current year|Aditxt Corp (ADTX) - Expected net earnings per share growth this year|Earnings per share growth in current year GRI Bio Corp (GRI)|XORTX Corp - Earnings per share growth this year|Earnings per share growth in current year Vyome Holdings Inc HIND|REVB - Net earnings per share growth this year|INDP: Net earnings per share growth this year|SCNI - Earnings growth in current year|calcimedica.com (CALI) - Earnings per share growth in current year|Earnings per share growth this year AFMD|ALLK (Allakos Inc) - Earnings growth in current year|Earnings per share growth rate in current year HOOKIPA HOOK|Net earnings per share growth this year IGMS (IGM Biosciences, Inc.)|ITOS (iTeos Therapeutics Inc) - Earnings per share increase in current year|Earnings growth in current year OCEA (Ocean Bio)|TC BioPharm Ltd - Earnings per share growth in current year|Third Harmonic Bio - Earnings growth in current year
